FDA approves BOOSTRIX for adults over 65 years

被引：0

|

作者：

不详

机构：

来源：

HUMAN VACCINES | 2011年 / 7卷 / 09期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：892 / 892

页数：1

相关论文

共 50 条

[1] FDA approves methlyphenidate HCI for the treatment of ADHD in adults 18-65 years of age
Ralat, Jose
CNS SPECTRUMS, 2008, 13 (09) : 749 - 749
[2] FDA approves first new ALS drug in over 20 years
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (06) : 375 - 375
[3] FDA approves first new ALS drug in over 20 years
Asher Mullard
Nature Reviews Drug Discovery, 2017, 16 : 375 - 375
[4] FDA approves new treatment for adults with migraine
不详
NURSE PRACTITIONER, 2020, 45 (05): : 56 - 56
[5] US FDA approves Fluzone® High-Dose influenza vaccine for the over 65s
不详
EXPERT REVIEW OF VACCINES, 2010, 9 (02) : 115 - 115
[6] FDA Approves Vilobelimab for Emergency Use in Hospitalized Adults
Harris, Emily
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (18): : 1544 - 1544
[7] FDA approves new indication for migraine prevention in adults
不详
NURSE PRACTITIONER, 2021, 46 (08): : 56 - 56
[8] FDA approves first new flu drug in 20 years
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (12) : 853 - 853
[9] FDA approves first new flu drug in 20 years
Asher Mullard
Nature Reviews Drug Discovery, 2018, 17 : 853 - 853
[10] EFFECTS OF EXERCISE ON FLEXIBILITY IN ADULTS OVER 65 YEARS OLD
Matos-Duarte, M.
Berlanga, L. A.
REVISTA INTERNACIONAL DE MEDICINA Y CIENCIAS DE LA ACTIVIDAD FISICA Y DEL DEPORTE, 2020, 20 (80): : 611 - 622

← 1 2 3 4 5 →